At last, the results of Gynecological Oncology Group (GOG) trial 99, a randomized trial comparing postoperative pelvic radiotherapy (RT) to no additional treatment (NAT) in intermediate-risk …

2019年4月17日 · The high-intermediate–risk criteria as defined in GOG-99 do seem to constitute a high-risk group of patients with recurrence rates of 15% to 20%, even with adjuvant …

Methods: Four hundred forty-eight consenting patients with "intermediate risk" endometrial adenocarcinoma were randomized after surgery to either no additional therapy (NAT) or whole …

The purpose of this study is to validate the Gynecologic Oncology Group (GOG) criteria for adjuvant treatment in a different cohort of patients and to evaluate the simplified risk criteria …

2019年6月12日 · In a randomized trial conducted by the Gynecologic Oncology Group (GOG), GOG 122, chemotherapy was found to be superior to radiotherapy in treating locally advanced …

GOG-99: ending the controversy regarding pelvic radiotherapy for endometrial carcinoma? GOG-99: ending the controversy regarding pelvic radiotherapy for endometrial carcinoma? Gynecol …

2007年1月23日 · In GOG-99 a high intermediate risk subgroup of patients were defined after randomisation as those with (i) grade 2 and 3, presence of lymphovascular invasion (LVC), …

(PORTEC)-1,2 and Gynecologic Oncology Group (GOG)-99 defined high-intermediate risk (HIR) group of surgically staged endometrial cancer patients and demonstrated decreasing …

2004年5月9日 · The goal of this study (GOG 99) was to investigate the utility of PORT in stage IB, IC and II (occult) patients having undergone complete surgical staging. Materials and …

2010年5月20日 · Background: GOG 99 defined a subgroup of patients with early stage endometrial cancer with high-intermediate-risk (H-IR) factors that were at recurrence risk of …